Association between Proton Pump Inhibitor Use and Risk of Hepatocellular Carcinoma: A Korean Nationally Representative Cohort Study

(1) Background: The association between proton pump inhibitor (PPI) use and hepatocellular carcinoma (HCC) has been controversial, especially in the general population. We aimed to determine the impact of PPI on HCC risk in participants without liver cirrhosis or chronic hepatitis virus infection. (...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Soungmun, Jeong, Seogsong, Park, Sun Jae, Chang, Jooyoung, Choi, Seulggie, Cho, Yoosun, Ahn, Joseph C., Lee, Gyeongsil, Son, Joung Sik, Park, Sang Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146713/
https://www.ncbi.nlm.nih.gov/pubmed/35628991
http://dx.doi.org/10.3390/jcm11102865

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146713/
https://www.ncbi.nlm.nih.gov/pubmed/35628991
http://dx.doi.org/10.3390/jcm11102865

Ejemplares similares